(Q33888474)

29 July 2017

title

Proteomic analysis of urinary upper gastrointestinal cancer markers (English)

1 reference

29 July 2017

Iain Gallagher

5

0 references

author name string

Holger Husi

1

1 reference

29 July 2017

Nathan Stephens

2

1 reference

29 July 2017

Andrew Cronshaw

3

1 reference

29 July 2017

Alisdair MacDonald

4

1 reference

29 July 2017

Carolyn Greig

6

1 reference

29 July 2017

Kenneth C H Fearon

7

1 reference

29 July 2017

James A Ross

8

1 reference

29 July 2017

publication date

28 April 2011

1 reference

Proteomics - Clinical Applications

29 July 2017

published in

1 reference

29 July 2017

volume

5

1 reference

29 July 2017

issue

5-6

1 reference

29 July 2017

page(s)

289-299

1 reference

Tumors of the esophagus, gastroesophageal junction, and stomach

29 July 2017

cites work

1 reference

https://api.crossref.org/works/10.1002%2FPRCA.201000107

Novel targets in esophageal and gastric cancer: beyond antiangiogenesis

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FPRCA.201000107

Novel targets in gastric and esophageal cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FPRCA.201000107

Validation of reverse phase protein array for practical screening of potential biomarkers in serum and plasma: accurate detection of CA19-9 levels in pancreatic cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FPRCA.201000107

Molecular identity of a pan cancer marker, CA215.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FPRCA.201000107

The level of carcinoembryonic antigen and the presence of mucin as predictors of cystic pancreatic mucinous neoplasia

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FPRCA.201000107

IPO-38 is identified as a novel serum biomarker of gastric cancer based on clinical proteomics technology

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FPRCA.201000107

Tumor M2 pyruvate kinase: a tumor marker and its clinical application in gastrointestinal malignancy

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FPRCA.201000107

High expression of tumour-associated trypsin inhibitor correlates with liver metastasis and poor prognosis in colorectal cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FPRCA.201000107

Prognostic markers in renal cell carcinoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FPRCA.201000107

Gene array studies in renal neoplasia.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FPRCA.201000107

The human urinary proteome contains more than 1500 proteins, including a large proportion of membrane proteins

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FPRCA.201000107

Body fluid proteomics for biomarker discovery: lessons from the past hold the key to success in the future

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FPRCA.201000107

Proteomic analyses of pancreatic cyst fluids

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FPRCA.201000107

Three new potential ovarian cancer biomarkers detected in human urine with equalizer bead technology

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FPRCA.201000107

Bikunin loss in urine as useful marker for bladder carcinoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FPRCA.201000107

Identification of urine PLK2 as a marker of bladder tumors by proteomic analysis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FPRCA.201000107

Identification of a biomarker panel using a multiplex proximity ligation assay improves accuracy of pancreatic cancer diagnosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FPRCA.201000107

Increased circulating cell signalling phosphoproteins in sera are useful for the detection of pancreatic cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FPRCA.201000107

Discovery of serum biomarkers for pancreatic adenocarcinoma using proteomic analysis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FPRCA.201000107

Dual-color proteomic profiling of complex samples with a microarray of 810 cancer-related antibodies

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FPRCA.201000107

Identification of a unique urinary biomarker profile in patients with autosomal dominant polycystic kidney disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FPRCA.201000107

Naturally occurring human urinary peptides for use in diagnosis of chronic kidney disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FPRCA.201000107

A review of experimental design best practices for proteomics based biomarker discovery: focus on SELDI-TOF.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FPRCA.201000107

Surface-enhanced laser desorption/ionization mass spectrometry for protein and Peptide profiling of body fluids

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FPRCA.201000107

Proteomics profiling of urine with surface enhanced laser desorption/ionization time of flight mass spectrometry

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FPRCA.201000107

Inciting inflammation: the RAGE about tumor promotion

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FPRCA.201000107

Isolation and identification of potential urinary microparticle biomarkers of bladder cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FPRCA.201000107

Bladder cancer associated glycoprotein signatures revealed by urinary proteomic profiling

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FPRCA.201000107

S100A6 overexpression is associated with poor prognosis and is epigenetically up-regulated in gastric cancer.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FPRCA.201000107

Increased cytoplasmic S100A6 expression is associated with pulmonary adenocarcinoma progression.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FPRCA.201000107

Gastric cancer-specific protein profile identified using endoscopic biopsy samples via MALDI mass spectrometry

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FPRCA.201000107

Improved diagnosis of colorectal cancer using a combination of fecal occult blood and novel fecal protein markers.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FPRCA.201000107

Expression of S100P and its novel binding partner S100PBPR in early pancreatic cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FPRCA.201000107

Proteomic analysis to identify biomarker proteins in pancreatic ductal adenocarcinoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FPRCA.201000107

Characterization of proteins in human pancreatic cancer serum using differential gel electrophoresis and tandem mass spectrometry

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FPRCA.201000107

Protein profiling of human breast tumor cells identifies novel biomarkers associated with molecular subtypes

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FPRCA.201000107

Stage-dependent increase of orosomucoid and zinc-alpha2-glycoprotein in urinary bladder cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FPRCA.201000107

Biomarker discovery: a proteomic approach for brain cancer profiling

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FPRCA.201000107

Complete analysis of the human mesotrypsinogen gene (PRSS3) in patients with chronic pancreatitis

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FPRCA.201000107

Clinical cancer proteomics: promises and pitfalls

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FPRCA.201000107

Recommendations for biomarker identification and qualification in clinical proteomics

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FPRCA.201000107

Zinc-alpha2-glycoprotein Expression as a Predictor of Metastatic Prostate Cancer Following Radical Prostatectomy

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FPRCA.201000107

Urinary excretion of twenty peptides forms an early and accurate diagnostic pattern of acute kidney injury

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FPRCA.201000107

21 January 2018

Identifiers

DOI

10.1002/PRCA.201000107

1 reference

29 July 2017

1 reference